Automated retrosynthesis strategies for accelerating drug discovery in rare disease research
automated retrosynthesis
drug discovery
rare diseases
AI chemistry
pharmaceutical research
Enhancing CRISPR-Cas9 precision with epigenetic reprogramming for targeted gene silencing
CRISPR-Cas9
epigenetic reprogramming
gene silencing
off-target effects
chromatin remodeling
Optimizing drug crystallization through solvent selection engines for polymorph control
solvent selection engines
drug crystallization
polymorph control
computational chemistry
pharmaceuticals
For senolytic drug discovery targeting mitochondrial dysfunction in aging cells
senolytic drugs
mitochondrial dysfunction
aging cells
drug discovery
senescence
During circadian rhythm minima: leveraging low-activity phases for targeted cancer therapy
circadian rhythms
cancer therapy
chronotherapy
drug timing
low-activity phases
Exploring the role of gut microbiome ecosystems in neurodegenerative disease progression
microbiome
neurodegeneration
neuroinflammation
alpha-synuclein
microbial metabolites
Targeting prion disease reversal through engineered CRISPR-Cas13 systems
prion disease
CRISPR-Cas13
neurodegenerative therapy
protein misfolding
RNA editing
Automated retrosynthesis for accelerated drug discovery using quantum-inspired algorithms
retrosynthesis
drug discovery
quantum algorithms
AI
pharmaceuticals
Targeting cellular senescence with senolytic drugs to extend human healthspan
cellular senescence
senolytics
healthspan extension
age-related diseases
drug discovery
Targeting prion disease reversal via CRISPR-Cas13 RNA editing
prion therapeutics
RNA interference
neurodegenerative diseases
CRISPR-Cas13
protein misfolding
Targeting prion disease reversal with CRISPR-based gene therapy approaches
prion disease
CRISPR
gene therapy
neurodegeneration
protein misfolding
Integrating neutrino physics with medical imaging for advanced tumor detection techniques
neutrino physics
medical imaging
tumor detection
radiation interaction
high-resolution imaging